SEC Tracker
Get the app

STAAR Surgical STAA

STAAR Surgical Q3 FY24: revenue $88.6M; diluted EPS $0.20

Form
10-Q
Filed
Period
Importance
Notable
Document
10-Q

Key figures from this report

These are the numbers STAAR Surgical reported for Q3 FY24, the quarter ended Sep 27, 2024, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Revenue$88.6MNo year-earlier figure tagged10-Q income statement, on EDGAR
  2. Net income$10.0MNo year-earlier figure tagged10-Q income statement, on EDGAR
  3. Diluted EPS$0.20No year-earlier figure tagged10-Q income statement, on EDGAR
  4. Cash and cash equivalents$164.0MNo year-earlier figure taggedCash and equivalents only; the company page adds short-term investments.10-Q balance sheet, on EDGAR
  5. Cash from operations$3.8MNo year-earlier figure tagged10-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters

Every quarter in the financial tables

View on EDGAR

Open in the app

Get an email when STAAR Surgical files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3851 and related industry codes: the same peer list as the financial tables.

  1. National Vision Holdings EYE public float $1.3B, Jun 28, 2025
  2. Bausch & Lomb BLCO public float $557M, Jun 30, 2025
  3. RxSight RXST public float $504M, Jun 30, 2025
  4. Warby Parker WRBY public float $2.2B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.